Generating Flawless Slides for Digital Pathology

Title: Generating Flawless Slides for Digital Pathology
Date: October 17, 2024
Time: 1 p.m. ET
Presenter: Andrew Lisowski, MS, HTL (ASCP), Senior Technical Content Manager at Epredia

Finding, Fixing, and Avoiding Workflow Errors
Improperly prepared stained slide sections can lead to a variety of problems in today’s histology lab, including scanning inefficiencies, expanded electronic file sizes, repeated tasks, slower turnaround times, higher costs, and delayed diagnoses.
In this webinar, we’ll discuss the specific challenges that impact the quality of stained sections. Each step of a routine staining workflow will be examined to pinpoint common mistakes that can negatively affect scanning performance—especially those that increase, delay, or suspend scanning times. Because many mistakes originate in the embedding and sectioning steps, numerous examples of these errors will be highlighted, as well as specific methods for fixing and avoiding them.
Learning Objectives
This webinar will help you:
- Recognize challenges that affect stained section quality
- Identify issues associated with the embedding and sectioning workflow steps
- Evaluate detailed examples of glass slides that create scanning problems
- Apply best practices for printing scannable barcodes
Watch on Demand Download Slides (PDF, 5.4MB)
Fisher Healthcare is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.™ Program. One P.A.C.E.™ credit-hour will be provided for this complimentary basic level program.
Presenter

Andrew Lisowski, MS, HTL (ASCP), Senior Technical Content Manager at Epredia
Andrew Lisowski has nearly 30 years of experience in histology and histotechnology. He attended veterinary school and earned his master’s degree in molecular biology. He has worked in histology, IHC and ISH labs, and cell culture labs, performed in-vitro and in-vivo toxicology assays, and been a member of a necropsy team. His work experience includes pharmaceutical companies, medical schools, and the founding of molecular and histology firms.